$AFCG
Advanced Flower Capital Inc.

2023 Q3 Form 10-Q Financial Statement

#000182252323000024 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022
Revenue $15.27M $16.10M $75.13M
YoY Change -15.81% -19.12% 100.55%
Cost Of Revenue $3.570M $3.313M $15.77M
YoY Change -6.66% -21.14% 89.45%
Gross Profit $10.48M $12.79M $59.37M
YoY Change -26.8% -18.57% 103.72%
Gross Profit Margin 68.62% 79.42% 79.02%
Selling, General & Admin $1.580M $1.626M $7.640M
YoY Change 6.05% 2.4% 25.72%
% of Gross Profit 15.08% 12.72% 12.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $5.151M $4.940M $23.41M
YoY Change -3.07% -14.68% 62.55%
Operating Profit $5.329M $7.846M $35.96M
YoY Change -40.8% -20.85% 143.93%
Interest Expense $1.533M $1.576M $6.814M
YoY Change -6.76% -9.8% 504.7%
% of Operating Profit 28.77% 20.08% 18.95%
Other Income/Expense, Net -$1.050M $1.606M -$11.18M
YoY Change 93.74% -200.82% 321.9%
Pretax Income $8.643M $12.30M $36.96M
YoY Change -25.8% 6.83% 75.7%
Income Tax $700.0K $200.0K $1.000M
% Of Pretax Income 8.1% 1.63% 2.71%
Net Earnings $7.980M $12.14M $35.93M
YoY Change -30.49% 6.9% 71.1%
Net Earnings / Revenue 52.25% 75.38% 47.82%
Basic Earnings Per Share $0.39 $0.59 $1.80
Diluted Earnings Per Share $0.39 $0.59 $1.79
COMMON SHARES
Basic Shares Outstanding 20.46M shares 20.46M shares 19.84M shares
Diluted Shares Outstanding 20.34M shares 20.32M shares 19.96M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.20M $82.08M $140.4M
YoY Change 101.54% 80.06% 28.49%
Cash & Equivalents $73.20M $82.08M $140.4M
Short-Term Investments
Other Short-Term Assets $500.0K $697.9K $460.8K
YoY Change -11.34% 12.57% -51.45%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $73.70M $82.78M $140.8M
YoY Change 99.82% 79.16% 27.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets
YoY Change
Total Long-Term Assets $371.4M $371.2M $378.3M
YoY Change -14.51% -10.14% 6.68%
TOTAL ASSETS
Total Short-Term Assets $73.70M $82.78M $140.8M
Total Long-Term Assets $371.4M $371.2M $378.3M
Total Assets $445.1M $454.0M $519.2M
YoY Change -5.56% -1.15% 11.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $800.0K $1.284M $836.6K
YoY Change -29.29% 30.14% -45.28%
Accrued Expenses $7.600M $6.576M $9.973M
YoY Change -44.52% -43.08% 11.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.20M $25.70M $82.23M
YoY Change -30.67% 8.58% -12.08%
LONG-TERM LIABILITIES
Long-Term Debt $87.90M $87.71M $97.13M
YoY Change -9.35% -9.41% 0.58%
Other Long-Term Liabilities $200.0K $259.2K $754.1K
YoY Change -70.96% -56.43% -54.98%
Total Long-Term Liabilities $88.10M $87.97M $97.89M
YoY Change -9.78% -9.7% -0.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.20M $25.70M $82.23M
Total Long-Term Liabilities $88.10M $87.97M $97.89M
Total Liabilities $106.3M $113.7M $180.1M
YoY Change -14.18% -6.12% -6.08%
SHAREHOLDERS EQUITY
Retained Earnings -$10.94M -$9.103M
YoY Change 634.93% 481.42%
Common Stock $204.6K $204.6K
YoY Change 0.46% 3.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $338.8M $340.3M $339.1M
YoY Change
Total Liabilities & Shareholders Equity $445.1M $454.0M $519.2M
YoY Change -5.56% -1.15% 11.69%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022
OPERATING ACTIVITIES
Net Income $7.980M $12.14M $35.93M
YoY Change -30.49% 6.9% 71.1%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $5.460M $5.146M $31.32M
YoY Change -55.36% -51.27% 228.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$4.520M $8.034M -$16.34M
YoY Change -76.7% -142.12% -93.42%
Cash From Investing Activities -$4.520M $8.034M -$16.34M
YoY Change -76.7% -142.12% -93.42%
FINANCING ACTIVITIES
Cash Dividend Paid $41.62M
YoY Change 189.23%
Common Stock Issuance & Retirement, Net $75.06M
YoY Change -59.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.820M -11.71M $16.15M
YoY Change 368.54% 23.0% -95.23%
NET CHANGE
Cash From Operating Activities 5.460M 5.146M $31.32M
Cash From Investing Activities -4.520M 8.034M -$16.34M
Cash From Financing Activities -9.820M -11.71M $16.15M
Net Change In Cash -8.880M 1.474M $31.13M
YoY Change -4.14% -108.17% -68.76%
FREE CASH FLOW
Cash From Operating Activities $5.460M $5.146M $31.32M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 afcg Severance Costs Period To Receive Base Salary
SeveranceCostsPeriodToReceiveBaseSalary
P12M
CY2023Q1 afcg Severance Cobra Premiums Paid Period
SeveranceCOBRAPremiumsPaidPeriod
P12M
CY2023Q2 afcg Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Extension
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodExtension
P1Y
CY2023Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
697888 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
460844 usd
CY2023Q2 us-gaap Assets
Assets
453986611 usd
CY2022Q4 us-gaap Assets
Assets
519176899 usd
CY2023Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1130541 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
3200944 usd
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
889167 usd
CY2023Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
9819695 usd
CY2023Q2 us-gaap Financing Receivable Covered Allowance For Credit Loss
FinancingReceivableCoveredAllowanceForCreditLoss
259174 usd
CY2023Q2 us-gaap Management Fee Payable
ManagementFeePayable
3313493 usd
CY2023Q2 afcg Accrued Direct Administrative Expenses
AccruedDirectAdministrativeExpenses
1242669 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1284153 usd
CY2023Q2 us-gaap Payable Investment Purchase
PayableInvestmentPurchase
7995934 usd
CY2022Q4 us-gaap Payable Investment Purchase
PayableInvestmentPurchase
0 usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
125 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20364000 shares
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
130769 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.48
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9819695 usd
CY2023Q2 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
60
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
7500 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
12135333 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
340318237 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
336510393 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1348811 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
117397 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.56
CY2022Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11120409 usd
CY2022Q2 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
60
CY2022Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
7500 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
11351673 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
338200365 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
399427 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.04
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
21293666 usd
us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
60
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
7500 usd
us-gaap Net Income Loss
NetIncomeLoss
22160607 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
340318237 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
273075174 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64321754 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1107420 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.11
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
21979026 usd
us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
60
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
7500 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
168750 usd
us-gaap Net Income Loss
NetIncomeLoss
21513793 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
338200365 usd
us-gaap Net Income Loss
NetIncomeLoss
22160607 usd
us-gaap Net Income Loss
NetIncomeLoss
21513793 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-903761 usd
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2498177 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-26384 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
450000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1986381 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1940609 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-924611 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2496655 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
8337513 usd
us-gaap Share Based Compensation
ShareBasedCompensation
399427 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1107420 usd
afcg Payment In Kind Interest
PaymentInKindInterest
8109786 usd
afcg Payment In Kind Interest
PaymentInKindInterest
3475182 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2652172 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
384377 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
145996 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-226826 usd
afcg Increase Decrease In Interest Reserve
IncreaseDecreaseInInterestReserve
3570403 usd
afcg Increase Decrease In Interest Reserve
IncreaseDecreaseInInterestReserve
-404344 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-147500 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-33507 usd
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-578241 usd
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
1378523 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-600983 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-118664 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
448783 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-536112 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9528462 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15226222 usd
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
16796204 usd
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
103799812 usd
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
21312827 usd
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
10600000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
15900000 usd
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
18509287 usd
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
28176844 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23025910 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-49122968 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
65971445 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1649691 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
225000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
19087523 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
75000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29765769 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-58293439 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-63662515 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45583533 usd
afcg Interest Reserve Withheld From Funding Of Loan
InterestReserveWithheldFromFundingOfLoan
0 usd
afcg Original Issue Discount Withheld From Funding Of Loans
OriginalIssueDiscountWithheldFromFundingOfLoans
4682675 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
168750 usd
afcg Securities Purchases Incurred But Not Yet Paid
SecuritiesPurchasesIncurredButNotYetPaid
7995934 usd
afcg Securities Purchases Incurred But Not Yet Paid
SecuritiesPurchasesIncurredButNotYetPaid
0 usd
afcg Dividends Declared But Not Yet Paid
DividendsDeclaredButNotYetPaid
9819695 usd
afcg Dividends Declared But Not Yet Paid
DividendsDeclaredButNotYetPaid
11120409 usd
us-gaap Interest Paid Net
InterestPaidNet
2951250 usd
us-gaap Interest Paid Net
InterestPaidNet
2972743 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
415359 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
40588 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses (“CECL”).</span></div>
CY2022 afcg Number Of Loans Held For Investments In Portfolio
NumberOfLoansHeldForInvestmentsInPortfolio
3 loan
afcg Number Of Loans Held For Investments In Portfolio
NumberOfLoansHeldForInvestmentsInPortfolio
3 loan
CY2023Q2 afcg Loans Held For Investment At Fair Value Aggregate Commitments
LoansHeldForInvestmentAtFairValueAggregateCommitments
98400000 usd
CY2022Q4 afcg Loans Held For Investment At Fair Value Aggregate Commitments
LoansHeldForInvestmentAtFairValueAggregateCommitments
104300000 usd
CY2023Q2 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
100300000 usd
CY2022Q4 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
102400000 usd
afcg Loans Held For Investment At Fair Value Funded Of Outstanding Principal
LoansHeldForInvestmentAtFairValueFundedOfOutstandingPrincipal
1700000 usd
afcg Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value
ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue
5900000 usd
CY2023Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
95940672 usd
CY2023Q2 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
99291215 usd
CY2023Q2 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
100271604 usd
afcg Loans Held For Investment At Fair Value Weighted Average Remaining Life
LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife
P0Y8M12D
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99226051 usd
CY2022Q4 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
100635985 usd
CY2022 afcg Loans Held For Investment At Fair Value Weighted Average Remaining Life
LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife
P1Y2M12D
CY2022Q4 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
102376546 usd
CY2022Q4 afcg Loans Held For Investment At Fair Value Original Issue Discount
LoansHeldForInvestmentAtFairValueOriginalIssueDiscount
1740561 usd
CY2022Q4 afcg Loans Held For Investment At Fair Value Unrealized Gains Losses
LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses
-1409934 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99226051 usd
afcg Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net
LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet
-1940609 usd
afcg Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net
LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet
-1940609 usd
afcg Loans Held For Investment At Fair Value Outstanding Principal New Fundings
LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings
1705873 usd
afcg Loans Held For Investment At Fair Value New Funding
LoansHeldForInvestmentAtFairValueNewFunding
1705873 usd
afcg Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount
LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount
760172 usd
afcg Loans Held For Investment At Fair Value Accretion Of Original Issue Discount
LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount
760172 usd
afcg Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value Outstanding Principal
ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValueOutstandingPrincipal
5897934 usd
afcg Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest
LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest
2087119 usd
afcg Loans Held For Investment At Fair Value Payment In Kind Interest
LoansHeldForInvestmentAtFairValuePaymentInKindInterest
2087119 usd
CY2023Q2 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
100271604 usd
CY2023Q2 afcg Loans Held For Investment At Fair Value Original Issue Discount
LoansHeldForInvestmentAtFairValueOriginalIssueDiscount
980389 usd
CY2023Q2 afcg Loans Held For Investment At Fair Value Unrealized Gains Losses
LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses
-3350543 usd
CY2023Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
95940672 usd
CY2023Q2 afcg Loans Held For Investment Cost
LoansHeldForInvestmentCost
99291215 usd
CY2023Q2 afcg Loans Held For Investment Outstanding Principal Amount
LoansHeldForInvestmentOutstandingPrincipalAmount
100271604 usd
afcg Number Of Loans Held For Investments
NumberOfLoansHeldForInvestments
8 loan
CY2022 afcg Number Of Loans Held For Investments
NumberOfLoansHeldForInvestments
9 loan
CY2023Q2 afcg Loans Held For Investment At Carrying Value Aggregate Commitments
LoansHeldForInvestmentAtCarryingValueAggregateCommitments
306300000 usd
CY2022Q4 afcg Loans Held For Investment At Carrying Value Aggregate Commitments
LoansHeldForInvestmentAtCarryingValueAggregateCommitments
338900000 usd
CY2023Q2 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
294800000 usd
CY2022Q4 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
296600000 usd
afcg Loans Held For Investment At Carrying Value Outstanding Principal New Fundings
LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings
27200000 usd
afcg Receivable With Imputed Interest Loan Repayments And Amortization Payments
ReceivableWithImputedInterestLoanRepaymentsAndAmortizationPayments
12400000 usd
afcg Receivable With Imputed Interest Sale Of Loans Face Amount
ReceivableWithImputedInterestSaleOfLoansFaceAmount
22600000 usd
CY2023Q2 afcg Percentage Of Loans Held With Floating Interest Rates
PercentageOfLoansHeldWithFloatingInterestRates
0.75
CY2022Q4 afcg Percentage Of Loans Held With Floating Interest Rates
PercentageOfLoansHeldWithFloatingInterestRates
0.73
CY2022Q4 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
296584529 usd
CY2022Q4 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
11407417 usd
CY2022Q4 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
285177112 usd
CY2022 afcg Loans Held For Investment Weighted Average Remaining Life
LoansHeldForInvestmentWeightedAverageRemainingLife
P3Y1M6D
CY2022Q4 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
296584529 usd
CY2022Q4 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
11407417 usd
CY2022Q4 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
285177112 usd
afcg Receivable With Imputed Interest New Funding Face Amount
ReceivableWithImputedInterestNewFundingFaceAmount
27196265 usd
afcg Receivable With Imputed Interest Discount On New Funding
ReceivableWithImputedInterestDiscountOnNewFunding
2610000 usd
afcg Receivable With Imputed Interest New Funding Net Amount
ReceivableWithImputedInterestNewFundingNetAmount
24586265 usd
afcg Receivable With Accretion Of Original Issue Discount Premium
ReceivableWithAccretionOfOriginalIssueDiscountPremium
1736483 usd
afcg Accretion Of Original Issue Discount Net Amount
AccretionOfOriginalIssueDiscountNetAmount
1736483 usd
afcg Receivable With Imputed Interest Loan Repayments Face Amount
ReceivableWithImputedInterestLoanRepaymentsFaceAmount
9586534 usd
afcg Receivable With Imputed Interest Loan Repayments
ReceivableWithImputedInterestLoanRepayments
9586534 usd
afcg Receivable With Imputed Interest Sale Of Loans Face Amount
ReceivableWithImputedInterestSaleOfLoansFaceAmount
22606578 usd
afcg Receivable With Imputed Interest Sale Of Loans Original Issue Discount
ReceivableWithImputedInterestSaleOfLoansOriginalIssueDiscount
1267367 usd
afcg Receivable With Sale Of Loans Net Amount
ReceivableWithSaleOfLoansNetAmount
21339211 usd
afcg Receivable With Paid In Kind Interest Face Amount
ReceivableWithPaidInKindInterestFaceAmount
6022667 usd
afcg Receivable With Paid In Kind Interest Net Amount
ReceivableWithPaidInKindInterestNetAmount
6022667 usd
afcg Receivable With Imputed Interest Amortization Payments
ReceivableWithImputedInterestAmortizationPayments
2844224 usd
afcg Receivable With Imputed Interest Loan Amortization Payments
ReceivableWithImputedInterestLoanAmortizationPayments
2844224 usd
CY2023Q2 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
294766125 usd
CY2023Q2 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
11013567 usd
CY2023Q2 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
283752558 usd
CY2023Q2 us-gaap Receivable With Imputed Interest Face Amount
ReceivableWithImputedInterestFaceAmount
294766125 usd
CY2023Q2 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
11013567 usd
CY2023Q2 afcg Loans Held For Investment Carrying Value
LoansHeldForInvestmentCarryingValue
283752558 usd
CY2022Q4 afcg Number Of Portfolio Loans
NumberOfPortfolioLoans
1 loan
CY2023Q2 afcg Number Of Portfolio Loans
NumberOfPortfolioLoans
1 loan
CY2022Q4 afcg Loans Receivable At Carrying Value Aggregate Commitments
LoansReceivableAtCarryingValueAggregateCommitments
4000000 usd
CY2023Q2 afcg Loans Receivable At Carrying Value Aggregate Commitments
LoansReceivableAtCarryingValueAggregateCommitments
4000000 usd
CY2023Q2 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2000000 usd
us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
200000 usd
CY2022Q4 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
2222339 usd
CY2022Q4 us-gaap Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount
FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount
1686 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2220653 usd
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
180595 usd
afcg Payments On Loans Receivable Carrying Value
PaymentsOnLoansReceivableCarryingValue
180595 usd
CY2023Q2 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
81460567 usd
CY2023Q2 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
184111617 usd
CY2023Q2 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
20220432 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
2878819 usd
us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
60417 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1293750 usd
CY2023Q2 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
38749 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
243276 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
1575775 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1437499 usd
CY2022Q2 us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
14583 usd
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
294922 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
1747004 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
2729167 usd
us-gaap Line Of Credit Facility Commitment Fee Amount
LineOfCreditFacilityCommitmentFeeAmount
74582 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
440186 usd
us-gaap Interest Expense
InterestExpense
3243935 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
507883 usd
us-gaap Interest Expense
InterestExpense
3447119 usd
CY2023Q2 afcg Contractual Obligation Loan Commitments
ContractualObligationLoanCommitments
408676412 usd
CY2022Q4 afcg Contractual Obligation Loan Commitments
ContractualObligationLoanCommitments
447101864 usd
CY2023Q2 afcg Contractual Obligation Drawn Loan Commitments
ContractualObligationDrawnLoanCommitments
396697725 usd
CY2022Q4 afcg Contractual Obligation Drawn Loan Commitments
ContractualObligationDrawnLoanCommitments
401476418 usd
CY2023Q2 us-gaap Contractual Obligation
ContractualObligation
11978687 usd
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
45625446 usd
CY2023Q1 afcg Severance Cobra Premiums Paid Percentage
SeveranceCOBRAPremiumsPaidPercentage
1
CY2023Q1 afcg Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Number Of Tranches
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingNumberOfTranches
1 tranche
us-gaap Severance Costs1
SeveranceCosts1
700000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3000000 shares
CY2022Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
20.50
CY2022Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
61500000 usd
CY2022Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3291832 shares
CY2022Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
67500000 usd
CY2022Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
63000000.0 usd
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000 usd
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
232489 shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
293420 shares
CY2023Q2 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares
2142143 shares
CY2022Q4 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares
2081212 shares
CY2023Q2 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative
5511 shares
CY2022Q4 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative
5511 shares
CY2023Q2 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares
95849 shares
CY2022Q4 afcg Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares
88749 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2273272 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2280372 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2280372 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7100 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.35
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2273272 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2321106 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.43
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2316106 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2280372 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7100 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.35
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2273272 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1604236 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.08
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
742000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.46
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
30130 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.05
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2316106 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
12135333 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
11351673 usd
us-gaap Net Income Loss
NetIncomeLoss
22160607 usd
us-gaap Net Income Loss
NetIncomeLoss
21513793 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7500 usd
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7500 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7500 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
7500 usd
CY2023Q2 us-gaap Dividends
Dividends
103805 usd
CY2022Q2 us-gaap Dividends
Dividends
35520 usd
us-gaap Dividends
Dividends
139277 usd
us-gaap Dividends
Dividends
63662 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
12024028 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12024028 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
21442631 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19518964 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
95845 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19614809 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.10
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2417817 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2369907 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1419700 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1419700 shares
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
CY2023Q2 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
0 usd
afcg Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains
ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains
0.04
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
95940672 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
95940672 usd
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
99226051 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
99226051 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
200000 usd
CY2023Q2 afcg Incentive Compensation
IncentiveCompensation
2400000 usd
afcg Incentive Compensation
IncentiveCompensation
5200000 usd
CY2022Q2 afcg Incentive Compensation
IncentiveCompensation
3400000 usd
afcg Incentive Compensation
IncentiveCompensation
6400000 usd
CY2023Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
4210695 usd
CY2022Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
5175454 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9000941 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
9929385 usd
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.11
CY2022 afcg Taxable Ordinary Income Per Share
TaxableOrdinaryIncomePerShare
1.11
CY2022 afcg Return Of Capital Distribution Per Share
ReturnOfCapitalDistributionPerShare
0
CY2022 afcg Section199 A Dividends
Section199ADividends
1.11
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.04
afcg Taxable Ordinary Income Per Share
TaxableOrdinaryIncomePerShare
1.04
afcg Return Of Capital Distribution Per Share
ReturnOfCapitalDistributionPerShare
0
afcg Section199 A Dividends
Section199ADividends
1.04

Files In Submission

Name View Source Status
0001822523-23-000024-index-headers.html Edgar Link pending
0001822523-23-000024-index.html Edgar Link pending
0001822523-23-000024.txt Edgar Link pending
0001822523-23-000024-xbrl.zip Edgar Link pending
afcg-20230630.htm Edgar Link pending
afcg-20230630.xsd Edgar Link pending
afcg-20230630xex311.htm Edgar Link pending
afcg-20230630xex312.htm Edgar Link pending
afcg-20230630xex321.htm Edgar Link pending
afcg-20230630xex322.htm Edgar Link pending
afcg-20230630_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
afcg-20230630_def.xml Edgar Link unprocessable
afcg-20230630_cal.xml Edgar Link unprocessable
afcg-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
afcg-20230630_pre.xml Edgar Link unprocessable
afcg-20230630_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending